Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Alcolea

Showing results (131-140 of 242) with videos related to

Pageof 25
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumMaria Franquesa-Mullerat, Alejandra O Morcillo-Nieto, José Enrique Arriola-Infante, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Bilingualism's protective effects in Alzheimer's disease: Mechanisms of resilience and resistanceWenfu Bao, Stephanie M Grasso, Isabel Sala, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisSonia Sirisi Dolcet, Érika Sánchez-Aced, Olivia Belbin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2024
Cortical microinfarcts in adults with Down syndrome assessed with 3T-MRIMateus Rozalem Aranha, Victor Montal, Hilde van den Brink, et al.
Molecular & Cellular Proteomics : MCP|January 5, 2019
Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal FluidAlberto Lleó, Raúl Núñez-Llaves, Daniel Alcolea, et al.
Neurobiology of Aging|April 14, 2015
Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's diseaseDaniel Alcolea, Eduard Vilaplana, Jordi Pegueroles, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 16, 2025
Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndromeMathias Sauer, Bárbara Fernandes Gomes, Parasto Shahrouki, et al.
Nature Communications|November 10, 2025
Plasma p-tau217 as a biomarker of Alzheimer's disease pathology in individuals with Down syndromeHanna Huber, Javier Arranz, Burak Arslan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 19, 2025
Study of brain perfusion in adults with Down syndrome along the Alzheimer's disease continuumMaria Franquesa-Mullerat, Alejandra O Morcillo-Nieto, José Enrique Arriola-Infante, et al.
Nature Communications|July 15, 2021
Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer's disease in adults with Down syndromeAlberto Lleó, Henrik Zetterberg, Jordi Pegueroles, et al.
Pageof 25

Showing results (131-140 of 242) with videos related to

Sort By:
Pageof 25
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumMaria Franquesa-Mullerat, Alejandra O Morcillo-Nieto, José Enrique Arriola-Infante, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Bilingualism's protective effects in Alzheimer's disease: Mechanisms of resilience and resistanceWenfu Bao, Stephanie M Grasso, Isabel Sala, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisSonia Sirisi Dolcet, Érika Sánchez-Aced, Olivia Belbin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2024
Cortical microinfarcts in adults with Down syndrome assessed with 3T-MRIMateus Rozalem Aranha, Victor Montal, Hilde van den Brink, et al.
Molecular & Cellular Proteomics : MCP|January 5, 2019
Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal FluidAlberto Lleó, Raúl Núñez-Llaves, Daniel Alcolea, et al.
Neurobiology of Aging|April 14, 2015
Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's diseaseDaniel Alcolea, Eduard Vilaplana, Jordi Pegueroles, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 16, 2025
Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndromeMathias Sauer, Bárbara Fernandes Gomes, Parasto Shahrouki, et al.
Nature Communications|November 10, 2025
Plasma p-tau217 as a biomarker of Alzheimer's disease pathology in individuals with Down syndromeHanna Huber, Javier Arranz, Burak Arslan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 19, 2025
Study of brain perfusion in adults with Down syndrome along the Alzheimer's disease continuumMaria Franquesa-Mullerat, Alejandra O Morcillo-Nieto, José Enrique Arriola-Infante, et al.
Nature Communications|July 15, 2021
Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer's disease in adults with Down syndromeAlberto Lleó, Henrik Zetterberg, Jordi Pegueroles, et al.
Pageof 25